Statement Of Financial Position [Abstract]

Hyloris Pharmaceuticals SA - Filing #3166138

Concept As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment
429,000 EUR
176,000 EUR
Intangible assets other than goodwill
3,828 EUR
3,607 EUR
Investments accounted for using equity method
3,801 EUR
3,948 EUR
Cash and cash equivalents
30,406 EUR
33,457 EUR
50,012 EUR
Assets
47,681 EUR
60,728 EUR
Equity and liabilities [abstract]
Equity [abstract]
Issued capital
140,000 EUR
140,000 EUR
Share premium
121,513 EUR
121,513 EUR
Other reserves
476,000 EUR
476,000 EUR
Equity
39,069 EUR
80,761 EUR
476,000 EUR
121,513 EUR
140,000 EUR
4,460 EUR
2,162 EUR
53,909 EUR
1,136 EUR
140,000 EUR
121,513 EUR
476,000 EUR
476,000 EUR
1,622 EUR
1,136 EUR
4,460 EUR
4,460 EUR
121,513 EUR
1,622 EUR
65,381 EUR
64,246 EUR
140,000 EUR
55,045 EUR
54,805 EUR
476,000 EUR
48,056 EUR
3,827 EUR
103,693 EUR
2,391 EUR
129,000 EUR
Liabilities [abstract]
Liabilities
8,613 EUR
6,819 EUR
Equity and liabilities
47,681 EUR
60,728 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.